한글목차

바이오테크놀로지 기기 시장은 2030년까지 749억 달러에 이를 것으로 전망입니다.

2023년에 514억 달러로 평가된 바이오테크놀로지 기기 시장은 2023년부터 2030년까지 복합 연간 성장률(CAGR) 5.5%로 성장하여 2030년에는 749억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 면역 측정 시스템은 복합 연간 성장률(CAGR) 4.5%로 성장을 지속하고, 분석 기간이 끝날 때까지 261억 달러에 달할 것으로 예측됩니다. DNA 시퀀싱 시스템 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 7.8%로 추정됩니다.

미국 시장은 137억 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 5.2%로 성장할 것으로 예측됩니다.

미국의 바이오테크놀로지 기기 시장은 2023년 137억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 119억 달러 규모에 이를 것으로 예측되며 예측 기간 동안 복합 연간 성장률(CAGR) 5.2%를 나타낼 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR) 각각 4.8%와 4.7%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 4.3%로 성장할 것으로 예측됩니다.

세계 생명 공학 장비 시장 - 주요 동향과 촉진요인 요약

과학적 진보의 최전선에 있는 생명공학산업은 질병치료부터 지속가능한 농업에 이르기까지 세계 과제를 다루고 있으며, 첨단 바이오테크놀로지 기기 수요에 박차를 가하고 있습니다. 연구개발에 대한 투자를 원동력으로 하는 이 분야의 진보는 유전자, 단백질, 세포분석에 혁명을 가져오고, 헬스케어, 농업, 환경과학에 큰 영향을 미치고 있습니다. 주요 시장 성장 촉진요인으로는 유전체학와 단백질체학의 진보, 규제 대응, 바이오 의약품의 확대 등을 들 수 있습니다.

업계가 진화함에 따라 생명 공학 장비는 자동화, 소형화 및 인공지능 기술과의 통합과 같은 동향과 함께 의료 진단 및 환경 생명 공학 기술 혁신을 계속 견인합니다. 유전체학와 단백질체학의 진보로 차세대 시퀀서, 질량 분석기, 크로마토그래피 시스템이 필요하지만, 규제 기준에 따라 정밀 기기 수요가 높아집니다. 바이오 의약품의 성장은 바이오 제조 장비 수요를 부추기고 기술 통합은 효율성과 의사 결정 프로세스를 강화합니다.

향후 AI의 통합과 지속가능성의 실천은 바이오테크놀로지 기기를 재형성하고, 높은 처리량 스크리닝을 지원하며, 포인트 오브 케어 검사 능력을 확대할 것입니다. 소형화는 유연한 사용을 가능하게 하고 AI와 머신러닝은 데이터 분석의 정확도를 향상시킵니다. 바이오테크놀로지 기기는 지속가능성과 요점 점검의 확대에 중점을 두면서 과학 연구와 건강 관리의 다양한 요구에 부응하고 진화를 계속하고 있습니다.

조사 대상 기업 예(전 147건)

• Abbott Laboratories
• Agilent Technologies, Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• GE HealthCare(UK)
• Gilson Inc.
• Harvard Bioscience Inc.
• Hitachi High-Technologies Corp.
• Illumina Inc.
• Lonza Group AG
• PerkinElmer Inc.
• Roche Diagnostics
• Shimadzu Corp.
• Siemens Healthineers
• Thermo Fischer Scientific Inc.
• Waters Corp.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 세계 기타 지역

제4장 경쟁

영문목차

Global Biotechnology Instrumentation Market to Reach US$74.9 Billion by 2030

The global market for Biotechnology Instrumentation estimated at US$51.4 Billion in the year 2023, is expected to reach US$74.9 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Immunoassay Systems, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$26.1 Billion by the end of the analysis period. Growth in the DNA Sequencing Systems segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Billion While China is Forecast to Grow at 5.2% CAGR

The Biotechnology Instrumentation market in the U.S. is estimated at US$13.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.9 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Biotechnology Instrumentation Market - Key Trends and Drivers Summarized

The biotechnology industry, at the forefront of scientific advancement, addresses global challenges from disease treatment to sustainable agriculture, spurring demand for sophisticated biotechnology instrumentation. Advancements in this field, driven by investments in R&D, revolutionize genetic, protein, and cellular analyses, impacting healthcare, agriculture, and environmental sciences profoundly. Key market growth drivers include advancements in genomics and proteomics, regulatory compliance, and the expansion of biopharmaceuticals.

As the industry evolves, biotechnology instruments will continue to drive innovation in medical diagnostics and environmental biotechnology, with trends leaning towards automation, miniaturization, and integration with AI technologies. Genomics and proteomics advancements necessitate next-generation sequencing devices, mass spectrometers, and chromatography systems, while regulatory standards drive demand for precise instrumentation. The growth of biopharmaceuticals fuels demand for bio-manufacturing instruments, and technological integration enhances efficiency and decision-making processes.

Looking ahead, AI integration and sustainability practices will reshape biotechnology instrumentation, supporting high-throughput screening and expanding point-of-care testing capabilities. Miniaturization allows for flexible use, while AI and machine learning improve data analysis accuracy. With a focus on sustainability and the expansion of point-of-care testing, biotechnology instrumentation continues to evolve, meeting the diverse needs of scientific research and healthcare.

Select Competitors (Total 147 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• GE HealthCare (UK)
• Gilson Inc.
• Harvard Bioscience Inc.
• Hitachi High-Technologies Corp.
• Illumina Inc.
• Lonza Group AG
• PerkinElmer Inc.
• Roche Diagnostics
• Shimadzu Corp.
• Siemens Healthineers
• Thermo Fischer Scientific Inc.
• Waters Corp.)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Biotechnology Instrumentation - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advances in Genomic Sequencing Technologies Propel Market Growth
  • Rising Demand for Personalized Medicine Strengthens Business Case for Biotechnology Instruments
  • Growing Application of CRISPR Technology Generates Demand for Advanced Instrumentation
  • Development of Portable and Miniaturized Instruments Accelerates Market Expansion
  • Integration of Artificial Intelligence in Biotechnology Instrumentation Enhances Efficiency
  • Innovations in Proteomics and Metabolomics Throw the Spotlight on Specialized Instruments
  • Expansion of Pharmaceutical and Biopharmaceutical Industries Spurs Market Growth
  • Focus on Drug Discovery and Development Sustains Growth in Biotechnology Instrumentation Market
  • Rising Incidence of Chronic Diseases Generates Demand for Diagnostic Instruments
  • Emphasis on High-Throughput Screening Expands Addressable Market Opportunity
  • Growth in Synthetic Biology Spurs Demand for Custom Instruments
  • Adoption of Cloud-Based Solutions Drives Adoption of Digital Biotechnology Instruments
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Biotechnology Instrumentation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Biotechnology Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for DNA Sequencing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for DNA Sequencing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for MicroArrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for MicroArrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Liquid Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Liquid Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Laboratory Automation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Laboratory Automation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Electrophoresis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Electrophoresis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Product Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other Product Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• JAPAN
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• CHINA
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 38: China Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: China 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• EUROPE
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 41: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 42: Europe Historic Review for Biotechnology Instrumentation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Europe 16-Year Perspective for Biotechnology Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• FRANCE
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 47: France Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: France Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: France 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• GERMANY
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 50: Germany Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Germany Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Germany 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 53: Italy Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Italy Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Italy 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 56: UK Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: UK Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: UK 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 59: Rest of Europe Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Rest of Europe Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Rest of Europe 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Biotechnology Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Asia-Pacific Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Asia-Pacific 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 65: Rest of World Recent Past, Current & Future Analysis for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Rest of World Historic Review for Biotechnology Instrumentation by Product Segment - Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Rest of World 16-Year Perspective for Biotechnology Instrumentation by Product Segment - Percentage Breakdown of Value Sales for Immunoassay Systems, DNA Sequencing Systems, Mass Spectrometry, MicroArrays, Liquid Chromatography Systems, Laboratory Automation, Electrophoresis Systems and Other Product Segments for the Years 2014, 2024 & 2030

IV. COMPETITION